or Try an Advanced Search...

    Adult Stem Cell Stocks List

    Symbol Grade Name % Change
    MESO C Mesoblast Limited -1.45
    BLFS C BioLife Solutions, Inc. 1.52
    BCLI F Brainstorm Cell Therapeutics Inc. -1.59
    BRTX F BioRestorative Therapies, Inc. 3.21
    FATE F Fate Therapeutics, Inc. -6.76
    View As Page of Charts
    Related Industries: Biotechnology Medical Instruments & Supplies
    Related Stock Lists: Biotechnology Stem Cell Biology Life Sciences Bone Bone Marrow Cell Biology Cell Product Cord Blood Induced Stem Cells Mesenchymal Stem Cell Regenerative Medicine Therapeutic Products Amyotrophic Lateral Sclerosis Back Pain Biopharmaceutical Blood Blood Cells Cardiovascular Disease Cell Encapsulation

    Related ETFs - A few ETFs which own one or more of the above listed Adult Stem Cell stocks.

    Symbol Grade Name Weight
    WDNA D WisdomTree BioRevolution Fund 1.09
    CNCR F Loncar Cancer Immunotherapy ETF 0.87
    PTH D Invesco DWA Healthcare Momentum ETF 0.66
    PSCH C PowerShares S&P SmallCap Health Care Portfolio 0.49
    QQQS C Invesco NASDAQ Future Gen 200 ETF 0.31
    View all Adult Stem Cell ETFs...
    Compare ETFs
    Compare CNCR to PTH Compare PTH to QQQS Compare WDNA to QQQS

        Adult Stem Cell Stocks Recent News

        Date Stock Title
        Nov 20 FATE Fate Therapeutics: FT819 Finding Bodes Well For Future Of SLE Treatment Options
        Nov 19 FATE Wall Street Breakfast Podcast: Fate Therapeutics Rises On Lupus Drug Data
        Nov 18 FATE Fate Therapeutics Shares Rise After 'Promising' Lupus Treatment Results
        Nov 18 FATE Fate stock rallies 37% on positive Phase 1 data for FT819, FT522
        Nov 18 FATE Fate Therapeutics Presents 6-Month Follow-up Data on First Patient Treated in Phase 1 Autoimmunity Study with Fludarabine-free Conditioning and FT819 Off-the-shelf, 1XX CAR T-cell Product Candidate at ACR Convergence
        Nov 18 FATE Fate Therapeutics Highlights FT522 Off-the-shelf, ADR-armed CAR NK Cell Product Candidate at 2024 ACR Convergence
        Nov 15 FATE Fate Therapeutics, Inc. (NASDAQ:FATE) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
        Nov 15 BRTX BioRestorative Therapies Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
        Nov 15 BLFS BioLife Solutions, Inc. (NASDAQ:BLFS) Just Reported And Analysts Have Been Cutting Their Estimates
        Related Industries: Biotechnology Medical Instruments & Supplies
        Related Stock Lists: Biotechnology Stem Cell Biology Life Sciences Bone Bone Marrow Cell Biology Cell Product Cord Blood Induced Stem Cells Mesenchymal Stem Cell Regenerative Medicine Therapeutic Products Amyotrophic Lateral Sclerosis Back Pain Biopharmaceutical Blood Blood Cells Cardiovascular Disease Cell Encapsulation
        Adult Stem Cell

        Adult stem cells are undifferentiated cells found in various tissues throughout the body that can divide and differentiate into specialized cell types. They are responsible for maintaining and repairing the tissue in which they are found. Adult stem cells are multipotent, meaning they can only differentiate into a limited number of cell types.

        Browse All Tags